Trial Profile
Phase I/II study of a chemotherapy combination consisting of pemetrexed and cisplatin with concomitant radiotherapy, followed by consolidation chemotherapy with pemetrexed in patients with locally advanced inoperable NSCLC.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jun 2011
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Lilly Espana
- 08 Jun 2011 New trial record